Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia by Massimo Breccia, Gioia Colafigli, Luisa Quattrocchi, elisabetta abruzzese, giuliana alimena

Subjects: “…CML, ponatinib, extramedullary localization…”
Get full text

The remarkable response to ponatinib therapy in a child with blastic phase of chronic myeloid leukemia by Tekin Aksu, Şule Ünal, Fatma Gümrük

Subjects: Get full text

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cel... by Nuno Cerveira, Rosa Branca Ferreira, Susana Bizarro, Cecília Correia, Lurdes Torres, Susana Lisboa, Joana Vieira, Rui Santos, Fernando Campilho, Carlos Pinho Vaz, Luís Leite, Manuel R. Teixeira, António Campos

Subjects: Get full text

Significance of Clinical-Pathological Correlation in Ponatinib Reactions by Judith Monserrat Corona Herrera, Fanny Carolina López Jiménez, Verónica Monserrat Díaz Sánchez, Betzabé Quiles Martínez, Marcela Saeb Lima, Silvia Méndez Flores

Subjects: “…Ponatinib…”
Get full text

Overcoming phenotypic switching: targeting protein-protein interactions in cancer by Christos Ladias, Pavlos Papakotoulas, Maria Papaioannou, Nikolaos A. Papanikolaou

Subjects: Get full text

Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia by Kota Yoshifuji, Koji Sasaki

Subjects: Get full text

Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients by Sarah Allegra, Emma Dondi, Francesco Chiara, Silvia De Francia

Subjects: Get full text

Ponatinib alleviates non-alcoholic steatohepatitis through TFEB-mediated autophagy by Zhuomiao Lin, Meiqing Yang, Xihui Yu, Guozhu Tan, Jiahong Zhong

Subjects: “…ponatinib…”
Get full text

Evaluation of CML TKI Induced Cardiovascular Toxicity and Development of Potential Rescue Strategies in a Zebrafish Model by Shan Cheng, Shan Cheng, Pan Jin, Heying Li, Duanqing Pei, Duanqing Pei, Duanqing Pei, Xiaodong Shu, Xiaodong Shu, Xiaodong Shu

Subjects: Get full text

Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia by Kazuki Tanimura, Kai Yamasaki, Yuki Okuhiro, Kota Hira, Chika Nitani, Keiko Okada, Hiroyuki Fujisaki, Kana Matsumoto, Junichi Hara

Subjects: Get full text

Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia by Fabio Giglio, Fabio Giglio, Edoardo Campodonico, Edoardo Campodonico, Francesca Lorentino, Francesca Lorentino, Maddalena Noviello, Elisabetta Xue, Raffaella Greco, Lorenzo Lazzari, Alessandro Bruno, Maria Teresa Lupo Stanghellini, Matteo Giovanni Carrabba, Roberta La Starza, Monica Casucci, Chiara Bonini, Chiara Bonini, Sabina Chiaretti, Jacopo Peccatori, Robin Foà, Fabio Ciceri, Fabio Ciceri

Subjects: “…ponatinib…”
Get full text

Ponatinib‐induced ichthyosiform eruption by Nicolas Kluger, Katriina Lappalainen, Perttu Koskenvesa

Subjects: Get full text

Ponatinib-induced pneumonitis with severe acute respiratory distress syndrome by Sofia Dinis Ferreira, Margarida Jardim, Margarida Câmara, Fernando Jacinto, Fernando Aveiro, José Júlio Nóbrega

Subjects: “…ponatinib…”
Get full text

Gossypol enhances ponatinib's cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT/LC3II/p62, and Bcl2/caspase-3 pathways by Hadeel H. Elkattan, Alaa E. Elsisi, Naglaa M. El-Lakkany

Subjects: Get full text

Drug-Induced Reorganisation of Lipid Metabolism Limits the Therapeutic Efficacy of Ponatinib in Glioma Stem Cells by Paula Aldaz, Ana Olias-Arjona, Irene Lasheras-Otero, Karina Ausin, Marta Redondo-Muñoz, Claudia Wellbrock, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Imanol Arozarena

Subjects: Get full text

Ponatinib Induces a Procoagulant Phenotype in Human Coronary Endothelial Cells via Inducing Apoptosis by Bálint Krajcsir, Marianna Pócsi, Zsolt Fejes, Béla Nagy, János Kappelmayer, Ildikó Beke Debreceni

Subjects: “…ponatinib therapy…”
Get full text

Ponatinib modulates the metabolic profile of obese mice by inhibiting adipose tissue macrophage inflammation by Zhuomiao Lin, Xiaochun Lin, Xiaochun Lin, Ying Lai, Congcong Han, Xinran Fan, Jie Tang, Shiqi Mo, Jiahui Su, Sijia Liang, Sijia Liang, Jinyan Shang, Xiaofei Lv, Siwan Guo, Ruiping Pang, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Jiaguo Zhou, Tingting Zhang, Tingting Zhang, Tingting Zhang, Feiran Zhang, Feiran Zhang

Subjects: “…ponatinib…”
Get full text

A Phase II Study of the Multikinase Inhibitor Ponatinib in Patients With Advanced, RET-Rearranged NSCLC by Justin F. Gainor, MD, Shirish Gadgeel, M.B.B.S., Sai-Hong I. Ou, MD, PhD, Beow Yeap, ScD, Gregory A. Otterson, MD, Alice T. Shaw, MD, PhD

Subjects: Get full text

A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia by Sara Galimberti, Elisabetta Abruzzese, Giacomo Luci, Claudia Baratè, Luigia Luciano, Alessandra Iurlo, Giovanni Caocci, Riccardo Morganti, Fabio Stefanelli, Antonello Di Paolo

Subjects: Get full text

Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib by Mario Manzanares, Mario Manzanares, Fernando Ramos-Martín, Sara Rodríguez-Mora, Sara Rodríguez-Mora, Guiomar Casado-Fernández, Guiomar Casado-Fernández, Clara Sánchez-Menéndez, Clara Sánchez-Menéndez, Clara Sánchez-Menéndez, Alicia Simón-Rueda, Alicia Simón-Rueda, Elena Mateos, Elena Mateos, Miguel Cervero, Miguel Cervero, Adam M. Spivak, Vicente Planelles, Montserrat Torres, Montserrat Torres, Valentín García-Gutiérrez, Mayte Coiras, Mayte Coiras

Subjects: Get full text